Gender-specific differences in muscle-invasive bladder cancer: The concept of sex steroid sensitivity

World Journal of Urology

Volumn 31, Issue 5, 2013, Pages 1059-1064

  Gakis, Georgios ^a   Stenzl, Arnulf ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Androgen; Estrogen; Muscle invasive bladder cancer; Prostate Stem Cell Antigen; Radical cystectomy; Single nucleotide polymorphism

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; SEX HORMONE;

ARTICLE; BLADDER TUMOR; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR INVASION;

DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GONADAL STEROID HORMONES; HUMANS; MALE; NEOPLASM INVASIVENESS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; URINARY BLADDER NEOPLASMS;

EID: 84884812420     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1037-z     Document Type: Article

References (36)

1. Najari BB, Rink M, Li PS, Karakiewicz PI, Scherr DS, Shabsigh R, Meryn S, Schlegel PN, Shariat SF (2012) Sex disparities in cancer mortality: the risks of being a man in the U. S. J Urol 12: 05774-05776.
2. Sammon JD, Morgan M, Djahangirian O, Trinh QD, Sun M, Ghani KR, Jeong W, Jhaveri J, Ehlert M, Schmitges J, Bianchi M, Shariat SF, Perrotte P, Rogers CG, Peabody JO, Menon M, Karakiewicz PI (2012) Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. BJU Int 110(9): 1301-1309.
3. Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH (2010) The effect of age and gender on bladder cancer: a critical review of the literature. BJU Int 105(3): 300-308.
4. Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M (2012) Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large german multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med 9(6): 481-489.
5. Hollenbeck BK, Dunn R, Ye Z, Hollingsworth JM, Skolarus TA, Kim SP, Montie JE, Lee CT, Wood DP Jr, Miller DC (2010) Delays in diagnosis and bladder cancer mortality. Cancer 116(22): 5235-5242.
6. Waliszewski P, Waliszewska MK, Hemstreet GP 3rd, Hurst RE (1997) Expression of sex steroid receptor genes and comodulation with retinoid signaling in normal human uroepithelial cells and bladder cancer cell lines. Urol Oncol 3(5-6): 141-147.
7. Mir C, Shariat SF, van der Kwast TH, Ashfaq R, Lotan Y, Evans A, Skeldon S, Hanna S, Vajpeyi R, Kuk C, Alkhateeb S, Morote J, van Rhijn BW, Bostrom P, Yao J, Miyamoto H, Jewett M, Fleshner N, Messing E, Zlotta AR (2011) Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study. BJU Int 108(1): 24-30.
8. Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS (2004) Androgen receptor expression is inversely correlated with pathologic tumour stage in bladder cancer. Urology 64(2): 383-388.
9. Bolenz C, Lotan Y, Ashfaq R, Shariat SF (2009) Estrogen and progesterone hormonal receptor expression in urothelial carcinoma of the bladder. Eur Urol 56(6): 1093-1095.
10. Gakis G, Efstathiou JA, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A (2012) ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. Eur Urol. doi: 10. 1016/j. eururo. 2012. 08. 009.
11. Gakis G, Schilling D, Bedke J, Sievert KD, Stenzl A (2010) Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery. BJU Int 105(4): 468-471.
12. Gakis G, Stenzl A, Renninger M (2012) Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy. Scand J Urol Nephrol. doi: 10. 3109/00365599. 2012. 723045.
13. Izumi K, Zheng Y, Hsu JW, Chang C, Miyamoto H (2011) Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Mol Carcinog. doi: 10. 1002/mc. 21833.
14. Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL, Netto GJ, Miyamoto H (2012) Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen. Mol Carcinog. doi: 10. 1002/mc. 21978.
15. Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C (2007) Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 99(7): 558-568.
16. Tuygun C, Kankaya D, Imamoglu A, Sertcelik A, Zengin K, Oktay M, Sertcelik N (2011) Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression. Urol Oncol 29(1): 43-51.
17. Beilin J, Ball EM, Favaloro JM, Zajac JD (2000) Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol 25(1): 85-96.
18. Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S (2012) Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int 109(11): 1716-1726.
19. Shen SS, Smith CL, Hsieh JT, Yu J, Kim IY, Jian W, Sonpavde G, Ayala GE, Younes M, Lerner SP (2006) Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumour tiss. Cancer 106(12): 2610-2616.
20. Tincello DG, Taylor AH, Spurling SM, Bell SC (2009) Receptor isoforms that mediate estrogen and progestagen action in the female lower urinary tract. J Urol 181(3): 1474-1482.
21. Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol 29(4): 457-463.
22. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD, PLCO Project Team (2011) Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA 305(22): 2295-2303.
23. Chu LW, Meyer TE, Li Q, Menashe I, Yu K, Rosenberg PS, Huang WY, Quraishi SM, Kaaks R, Weiss JM, Hayes RB, Chanock SJ, Hsing AW (2010) Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin. Cancer Epidemiol Biomarkers Prev 19(7): 1848-1854.
24. Ishak MB, Giri VN (2011) A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies. Cancer Epidemiol Biomarkers Prev 20(8): 1599-1610.
25. Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang ZF, Kiltie AE, Bishop DT, Vineis P, Porru S, Buntinx F, Kellen E, Zeegers MP, Kumar R, Rudnai P, Gurzau E, Koppova K, Mayordomo JI, Sanchez M, Saez B, Lindblom A, de Verdier P, Steineck G, Mills GB, Schned A, Guarrera S, Polidoro S, Chang SC, Lin J, Chang DW, Hale KS, Majewski T, Grossman HB, Thorlacius S, Thorsteinsdottir U, Aben KK, Witjes JA, Stefansson K, Amos CI, Karagas MR, Gu J (2009) Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 41(9): 991-995.
26. Bahrenberg G, Brauers A, Joost HG, Jakse G (2000) Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun 275(3): 783-788.
27. Jain A, Lam A, Vivanco I, Carey MF, Reiter RE (2002) Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol Endocrinol 16(10): 2323-2337.
28. Zhigang Z, Wenlus S (2008) Flutamide reduced prostate cancer development and prostate stem cell antigen mRNA expression in high grade prostatic intraepithelial neoplasia. Int J Cancer 122(4): 864-870.
29. Wang S, Tang J, Wang M, Yuan L, Zhang Z (2010) Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population. Carcinogenesis 31(4): 621-624.
30. Gu Z, Thomas G, Yamashiro J, Shintaku IP, Dorey F, Raitano A, Witte ON, Said JW, Loda M, Reiter RE (2000) Prostate Stem Cell Antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 19(10): 1288-1296.
31. Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, Chen D, Seo K, Modrusan Z, Gao WQ, Settleman J, Johnson L (2011) Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy. Cancer Res. doi: 10. 1158/0008-5472. CAN-11-3004.
32. Kauffman EC, Robinson BD, Downes MJ, Powell LG, Lee MM, Scherr DS, Gudas LJ, Mongan NP (2011) Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog 501(12): 931-944.
33. Metzger E, Wissmann M, Yin N, Müller JM, Schneider R, Peters AH, Günther T, Buettner R, Schüle R (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437(7057): 436-439.
34. Miyake H, Hara I, Yamanaka K, Muramaki M, Eto H (2005) Prognostic significance of insulin-like growth factor (IGF) binding protein-2 to IGF-binding protein-3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder. BJU Int 95(7): 987-991.
35. Reis-Filho JS, Pusztai L (2011) Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet 378(9805): 1812-1823.
36. Gakis G, Schwentner C, Todenhoefer T, Stenzl A (2012) Current status of molecular markers for prognostication and outcome in invasive bladder cancer. BJU Int. doi: 10. 1111/j. 1464-410X. 2011. 10839. x.